Xarelto — Medical Mutual
Peripheral Artery Disease
Initial criteria
- Patient will be taking concomitant aspirin at least 75 mg daily
Reauthorization criteria
- Response to therapy is required for continuation unless otherwise noted
Approval duration
2 years